Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
Business Wire (Mar 12, 2013)
-
Business Wire (Feb 27, 2013)
-
-
-
-
A Regenerative Medicine Company To Watch Out ForGeorge Jarkesy • Wed, May 23, 2012 -
Record 1Q Sales: Nerve Regeneration Products Gaining TractionCockrell Group • Wed, May 16, 2012
-
AxoGen's Got Nerve: Noble Financial Initiates With 'Buy' RatingCockrell Group • Thu, Apr 19, 2012
-
AxoGen: A Formidable Player In Regenerative MedicineCockrell Group • Wed, Mar 28, 2012
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
A Regenerative Medicine Company To Watch Out ForGeorge Jarkesy • Wed, May 23, 2012
-
Record 1Q Sales: Nerve Regeneration Products Gaining TractionCockrell Group • Wed, May 16, 2012
-
AxoGen's Got Nerve: Noble Financial Initiates With 'Buy' RatingCockrell Group • Thu, Apr 19, 2012
-
AxoGen: A Formidable Player In Regenerative MedicineCockrell Group • Wed, Mar 28, 2012
There are no Related articles on AXGN.OB.
-
Business Wire (Mar 12, 2013)
-
Business Wire (Feb 27, 2013)
AXGN.OB vs. ETF Alternatives
Company Description
AxoGen (OTCBB: AXGN) is a regenerative medicine company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration. Every day people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves.... More